Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?'. Together they form a unique fingerprint.

Medicine & Life Sciences